Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata

Journal of Cellular Biochemistry

Volumn 99, Issue 5, 2006, Pages 1420-1430

  Son, Young Ok ^a   Choi, Ki Choon ^b   Lee, Jeong Chae ^a   Kook, Sung Ho ^a   Lee, Hyun Jeong ^c   Jeon, Young Mi ^a   Kim, Jong Ghee ^a   Kim, Ju ^a   Lee, Won Keun ^d   Jang, Yong Suk ^a  

^a Chonbuk National University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c National Institute of Animal Science   (South Korea)

^d Myong Ji University   (South Korea)

Author keywords

Akata cells; Apoptosis; Epstein Barr virus; Trichostatin A

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE; CATHEPSIN B; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BID; PROTEIN INHIBITOR; TRICHOSTATIN A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENICITY; CELL CYCLE G1 PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN AKATA; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MITOCHONDRION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN DEGRADATION; SENSITIVITY AND SPECIFICITY; STAINING; STRESS; VIRUS INFECTION; WESTERN BLOTTING;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BURKITT LYMPHOMA; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; ENZYME ACTIVATION; ENZYME INHIBITORS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROXAMIC ACIDS; IN SITU NICK-END LABELING; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES;

HUMAN HERPESVIRUS 4;

EID: 33751169811     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21022     Document Type: Article

References (32)

1. Ailenberg M, Silverman M. 2003. Differential effects of trichostatin A on gelatinase A expression in 3T3 fibroblasts and HT-1080 fibrosarcoma cells: Implications for use of TSA in cancer therapy. Biochem Biophys Res Commun 302:181-185.
2. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF. 2003. Apoptosis induced in neuronal cells by oxidative stress: Role played by caspases and intracellular calcium ions. Toxicol Lett 139:125-133.
3. Arends MJ, Morris RG, Wyllie AH. 1990. Apoptosis: The role of endonucleases. Am J Pathol 136:593-608.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Chang LK, Liu ST. 2000. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res 28:3918-3925.
6. Davies AH, Grand RJ, Evans FJ, Rickinson AB. 1991. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C. J Virol 65:6838-6844.
7. Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A, Palmieri M. 2003. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 38:59-69.
8. waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biol Chem 381:107-112.
9. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkkit's lymphoma. Lancet 1:702-703.
10. (Waf1, Cip1, sdi1) expression in Hep3B cells. Exp Cell Res 253:618-628.
11. Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini C. 2003. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278:12579-12589.
12. Herold C, Ganslmayer M, Ocker M, Hermann M, Geerts A, Hahn EG, Schuppan D. 2002. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol 36:233-240.
13. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. 1997. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
14. Komano J, Sugiura M, Takada K. 1998. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol 72:9150-9156.
15. Kook SH, Son YO, Han SK, Lee HS, Kim BT, Jang YS, Choi KC, Lee KS, Kim SS, Lim JY, Jeon YM, Kim JG, Lee JC. 2005. Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. J Biochem Mol Biol 38:755-762.
16. Kwon HJ, Owa T, Hassig CA, Shimada J, Schreiber SL. 1998. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci USA 95:3356-3361.
17. Kyrylenko S, Kyrylenko O, Suuronen T, Salminen A. 2003. Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases. Cell Mol Life Sci 60:1990-1997.
18. Liu J, Weiss A, Durrant D, Chi NW, Lee RM. 2004. The cardiolipin-binding domain of Bid affects mitochondrial respiration and enhances cytochrome c release. Apoptosis 9:533-541.
19. Medina V, Edmonds B, Young GP, James R, Appleton S, Zalewski PD. 1997. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 57:3697-3707.
20. Miller CL, Lee JH, Kieff E, Longnecker R. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci USA 91:772-776.
21. Papeleu P, Loyer P, Vanhaecke T, Elaut G, Geerts A, Guguen-Guillouzo C, Rogiers V. 2003. Trichostatin A induces differential cell cycle arrests but does not induce apoptosis in primary cultures of mitogen-stimulated rat hepatocytes. J Hepatol 39:374-382.
22. Patel T, Gores GJ, Kaufmann SH. 1996. The role of proteases during apoptosis. FASEB J 10:587-597.
23. Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O. 2003. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101:3451-3459.
24. Roh MS, Kim CW, Park BS, Kim GC, Jeong JH, Kwon HC, Suh DJ, Cho KH, Yee SB, Yoo YH. 2004. Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells. Apoptosis 9:583-589.
25. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743-2751.
26. Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. 2001. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci USA 98:10833-10838.
27. Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D. 1999. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274:34940-34947.
28. Shimizu N, Tanabe-Tochikura A, Kuroiwa Y, Takada K. 1994. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: Malignant phenotypes of BL cells are dependent on EBV. J Virol 68:6069-6073.
29. Westphal EM, Blackstock W, Feng W, Israel B, Kenney SC. 2000. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: A potential method for treating EBV positive malignancies. Cancer Res 60:5781-5788.
30. Wharton W, Savell J, Cress WD, Seto E, Pledger WJ. 2000. Inhibition of mitogenesis in Balb/c-3T3 cells by Trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes. J Biol Chem 275:33981-33987.
31. 2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase. J Biol Chem 275:21302-21308.
32. Zhu WG, Lakshmanan RR, Beal MD, Otterson GA. 2001. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res 61:1327-1333.